UPDATE: Don't dump biotechnology stocks yet, says chart guru Thomas Dorsey
Don't bet against biotechs yet, says chart guru Thomas Dorsey
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
A low-cost ETF to gain access to a basket of firms whose success hinges on consumer sentiment.
These intermediate-term offerings have consistently outperformed the Barclays Index, in some cases by taking a different approach.
An idea so contrarian that few ETFs exist to capitalize on it.